Table 2.
Demographics and characteristics of the non-diabetic subjects.
| Non-Obese (n = 77) | Obese (n = 60) | p-value | |
|---|---|---|---|
| Age | 41.00 (31.00–52.00) | 46.00 (33.75–56.00) | 0.09 |
| Gender (Male) | 28 (36.4%) | 24 (40.0%) | 0.79 |
| BMI | 24.71 (22.46–26.86) | 34.02 (31.60–36.16) | <0.001 |
| Waist/Hip Ratio | 0.84 (0.79–0.89) | 0.90 (0.82–0.97) | <0.01 |
| TC (mmol/L) | 5.00 (4.35–5.75) | 5.20 (4.60–5.90) | 0.41 |
| HDL (mmol/L) | 1.36 (1.09–1.66) | 1.17 (1.01–1.44) | <0.05 |
| LDL (mmol/L) | 3.10 (2.50–3.90) | 3.50 (2.80–3.85) | 0.24 |
| TGL (mmol/L) | 0.81 (0.60–1.09) | 1.12 (0.66–1.55) | <0.05 |
| FPG (mmol/L) | 5.07 (4.80–5.47) | 5.20 (4.90–5.80) | <0.05 |
| HbA1c (DCCT %) | 5.50 (5.30–5.80) | 5.70 (5.38–5.93) | 0.08 |
| Insulin (mIU/L) | 7.71 (5.21–15.14) | 15.43 (8.10–29.18) | <0.001 |
| Adiponectin (μg/mL) | 4.88 (3.21–7.40) | 4.07 (2.45–5.57) | 0.06 |
| Leptin (ng/mL) | 5.19 (2.69–7.84) | 10.07 (6.79–13.51) | <0.001 |
| PAI-1 (ng/mL) | 13.05 (10.01–16.73) | 15.65 (12.55–19.13) | <0.01 |
| IL-6 (pg/mL) | 16.56 (13.19–19.77) | 16.52 (14.17–20.89) | 0.56 |
| TNF alpha (pg/mL) | 122.25 (104.67–160.75) | 125.95 (102.36–141.80) | 0.54 |
| hsCRP(μg/mL) | 1.06 (0.55–3.04) | 3.07 (1.69–6.53) | <0.001 |
| Hypertension | 8 (10.4%) | 8 (13.3%) | 0.79 |
| Hyperlipidemia | 6 (7.8%) | 7 (11.7%) | 0.64 |
Median (IQR) presented for continuous variables and N (%) presented for categorical variables. P values were calculated using Mann–Whitney U test for continuous variables and chi-squared test for categorical variables. BMI, body mass index; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; hsCRP, high sensitivity c-reactive protein; IL-6, interleukin-6; LDL, low-density lipoprotein; PAI-1, plasminogen activator inhibitor-1; TGL, triglycerides; TNF alpha, tumor necrosis factor alpha.